Shares of Veeva Systems Inc. (NYSE:VEEV – Get Free Report) have received an average rating of “Moderate Buy” from the twenty-five research firms that are covering the stock, Marketbeat reports. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and fifteen have issued a buy rating on the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $255.28.
A number of equities analysts have weighed in on the stock. Canaccord Genuity Group upped their price objective on shares of Veeva Systems from $210.00 to $270.00 and gave the company a “hold” rating in a research report on Friday, December 6th. JPMorgan Chase & Co. upped their price objective on shares of Veeva Systems from $208.00 to $218.00 and gave the company a “neutral” rating in a research report on Monday, December 16th. Bank of America upped their price objective on shares of Veeva Systems from $280.00 to $290.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. KeyCorp decreased their price objective on shares of Veeva Systems from $285.00 to $255.00 and set an “overweight” rating for the company in a research report on Wednesday, January 8th. Finally, Evercore ISI upped their price objective on shares of Veeva Systems from $220.00 to $245.00 and gave the company an “in-line” rating in a research report on Friday, December 6th.
Check Out Our Latest Analysis on Veeva Systems
Hedge Funds Weigh In On Veeva Systems
Veeva Systems Trading Down 3.0 %
Shares of NYSE VEEV opened at $239.38 on Tuesday. Veeva Systems has a 12-month low of $170.25 and a 12-month high of $258.93. The company has a market cap of $38.86 billion, a P/E ratio of 59.11, a P/E/G ratio of 1.89 and a beta of 0.88. The stock has a fifty day moving average price of $225.47 and a 200 day moving average price of $220.64.
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading
- Five stocks we like better than Veeva Systems
- What is the Euro STOXX 50 Index?
- How to Protect Your Portfolio When Inflation Is Rising
- Stock Sentiment Analysis: How it Works
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Business Services Stocks Investing
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.